Dr. Lesley Russell Joins the Endocyte Board of Directors

Endocyte, Inc. (Nasdaq: ECYT ), a biopharmaceutical company developing targeted small molecule drug conjugates (SMDCs) and companion imaging diagnostics for personalized therapy in cancer and other serious diseases, today announced Lesley Russell, M.B.Ch.B., has joined the Endocyte board of directors. Dr. Russell served as senior vice president and head of